Steven Cohen’s MaxCyte MXCT Stock Holding History

Steven Cohen’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$369K	Buy	+299,853	New	+$299K	﹤0.01%	3305
2026 Q1	–	Sell	-106,151	Closed	-$165K	–	4232
2025 Q4	$165K	Sell	106,151 -271,888	-72%	-$434K	﹤0.01%	3676
2025 Q3	$597K	Buy	+378,039	New	+$657K	﹤0.01%	1866
2023 Q4	–	Sell	-33,200	Closed	-$104K	–	2581
2023 Q3	$104K	Sell	33,200 -67,800	-67%	-$273K	﹤0.01%	1959
2023 Q2	$464K	Buy	101,000 +66,800	+195%	+$307K	﹤0.01%	1278
2023 Q1	$169K	Sell	34,200 -386,857	-92%	-$1.9M	﹤0.01%	1531
2022 Q4	$2.3M	Buy	421,057 +386,157	+1,106%	+$2.37M	0.01%	916
2022 Q3	$227K	Buy	+34,900	New	+$195K	﹤0.01%	1257

Other funds holding MXCT

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $128M AUM

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Steven Cohen's MXCT Position: Q2 2026 in Review

Steven Cohen opened a new position in MaxCyte (MXCT) in Q2 2026: 299,853 shares worth $369K. The stake represents ﹤0.01% of the portfolio and ranks #3305 among its holdings. This is a return to the name: Steven Cohen previously reported a position in MXCT as recently as Q4 2025.

Steven Cohen first reported a position in MXCT in Q3 2022 and has held it in 8 quarters since. The position peaked at $2.3M in Q4 2022. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

Steven Cohen held 299,853 shares of MaxCyte worth $369K as of Q2 2026.
MaxCyte was a new Steven Cohen position in Q2 2026.
MaxCyte made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3305 holding.
Steven Cohen first reported a position in MaxCyte in Q3 2022 and has held it in 8 quarters since.
Steven Cohen's MaxCyte position peaked at $2.3M in Q4 2022.
123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.